← Leaderboards
Robert Morris Blanton
Tufts Medical Center
$5,432,727
Attributed
$5,432,727
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $844K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,432,727 · 3
By mechanism
R01$5,278,099 · 2
R03$154,628 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts Medical Center
Same institution · by research overlap
- Ronald D Perrone$9,263,101
- Iris Z Jaffe$20,757,672
- Daniel E Cox$1,964,998
- Michael E Mendelsohn$8,988,947
- Krishna C Penumatsa$2,572,205
Others in their field
Top investigators on “Syndrome”
- David Heimbrook · Leidos Biomedical Research, Inc.$365,165,418
- George R Seage · Abt Associates, Inc.$241,364,559
- Barbara Driver · Westat, Inc.$177,853,041
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$174,377,607
- Michelle Vargas · Ppd Development Lp$163,846,102
- Judith S. Currier · University Of California Los Angeles$149,333,820
Research focus
SyndromeResponseSildenafilIn VivoPressureCyclic Gmp-Dependent Protein KinasesSignal TransductionHeartMixed Lineage Kinase 3Cardiac MyocytesPathologicIn VitroPhosphotransferasesBlood VesselsHeart FailureBlood PressurePharmaceutical PreparationsPreclinical StudyHypotensionImproved OutcomeHypertensionMediatingMyocardiumBlood Pressure Regulation
Grant awards (11)
Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure$843,983
R01 · FY2025 · HL · contact PI
Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure$827,104
R01 · FY2024 · HL · contact PI
Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure$763,205
R01 · FY2023 · HL · contact PI
Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure$718,807
R01 · FY2022 · HL · contact PI
Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control$427,500
R01 · FY2020 · HL · contact PI
Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control$427,500
R01 · FY2019 · HL · contact PI
Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control$426,250
R01 · FY2018 · HL · contact PI
Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control$423,750
R01 · FY2017 · HL · contact PI
Novel Protein Kinase GI Substrates in Cardiac Remodeling and Blood Pressure Control$420,000
R01 · FY2016 · HL · contact PI
Cardiac Myocycte-Role of PKG I Alpha in Aging-Dependent Cardiac Remodeling$75,128
R03 · FY2013 · AG · contact PI
Cardiac Myocyte-Specific Role of PKG I Alpha in Aging-Dependent Cardiac Remodelin$79,500
R03 · FY2012 · AG · contact PI